Pharmig India 2025 Set To Bring Global Microbiology Leaders Under One RoofPharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors.
By: Pharmanow Positioned at the intersection of global regulatory expectations and next-generation microbial control strategies, Pharmig India 2025 will feature sessions on:
Representatives can expect to hear from thought leaders representing major global pharma companies, regulatory bodies, and consultancy experts who shape microbiology standards internationally. This makes the forum a high-value knowledge hub for QA/QC heads, sterility assurance professionals, regulatory affairs teams, microbiology managers, production leaders, and anyone responsible for maintaining microbial control in sterile or non-sterile environments. Following the revised EU Annex 1, microbiology is gaining greater regulatory scrutiny. Indian pharma manufacturers are accelerating their focus on risk-based contamination control, vigorous EM programs, and strengthened aseptic governance. Pharmig India 2025 (https://www.pharmanow.live/ Attendees will have the chance to participate in intensive discussions, interactive Q&A sessions, and practical learning modules that go beyond presentations to address everyday challenges faced in QC labs and manufacturing floors. As India continues to be a global pharma powerhouse, Pharmig India 2025 stands ready to elevate microbiology knowledge, harmonise best practices, and inspire a stronger culture of contamination control across the industry End
|
|